 |
|
Stem cell treatment succeeds in spinal cord-injured rats
March 29, 2006Stem cells can repair damaged spinal tissue and help restore function in rats with spinal cord injuries, according to a new study. The findings may eventually lead to insights that result in new treatments for humans with spinal cord injuries.
Michael Fehlings, MD, PhD, and his colleagues at the Krembil Neuroscience Center at Toronto Western Research Institute and the University of Toronto also identified a critical window during which stem cell transplants may be effective, says the study, which appears in the March 29 issue of The Journal of Neuroscience.
"This work breaks new ground by showing that therapeutically useful stem cells can be derived from the adult brain of rodents, and that these cells can be caused to differentiate into the types of cells that are useful for repairing the damaged spinal cord," says Oswald Steward, PhD, director of the Reeve-Irvine Research Center for Spinal Cord Injury at the University of California, Irvine.
Fehlings' team used cells from the brains of adult mice labeled with a fluorescent marker, enabling them to trace the cells after they were transplanted into rats whose spines had been crushed. Stem cells transplanted up to two weeks after the initial injury survived thanks to a cocktail of growth factors and immune-suppressing drugs the team developed. More than one-third of the transplanted cells traveled along the spinal cord, were incorporated into damaged tissue, developed into the type of cell destroyed at the injured site, and produced myelin, an insulating layer around nerve fibers that transmits signals from the brain.
An injured spinal cord loses its ability to regenerate myelin-forming cells, leading to paralysis. Fehlings showed that where stem cells restored myelin in the injured spine, rats showed some recovery and walked with more coordination.
One new aspect demonstrated by the study is that "the maximal effect of transplanting these cells is early after injury," says New York University School of Medicine professor Moses Chao, PhD. "The timing of neural stem cell application therefore is critical to successful therapy in the injured spinal cord."
One focus of future research will be to determine the reason why stem cells transplanted weeks or months later fail to function or sometimes even survive.
Each year, some 11,000 Americans sustain spinal cord injury, most often in traffic accidents. Costs of the condition approach $10 billion per year.
Society for Neuroscience
Fehlings' team used cells from the brains of adult mice labeled with a fluorescent marker, enabling them to trace the cells after they were transplanted into rats whose spines had been crushed. Stem cells transplanted up to two weeks after the initial injury survived thanks to a cocktail of growth factors and immune-suppressing drugs the team developed. More than one-third of the transplanted cells traveled along the spinal cord, were incorporated into damaged tissue, developed into the type of cell destroyed at the injured site, and produced myelin, an insulating layer around nerve fibers that transmits signals from the brain.
An injured spinal cord loses its ability to regenerate myelin-forming cells, leading to paralysis. Fehlings showed that where stem cells restored myelin in the injured spine, rats showed some recovery and walked with more coordination.
One new aspect demonstrated by the study is that "the maximal effect of transplanting these cells is early after injury," says New York University School of Medicine professor Moses Chao, PhD. "The timing of neural stem cell application therefore is critical to successful therapy in the injured spinal cord."
One focus of future research will be to determine the reason why stem cells transplanted weeks or months later fail to function or sometimes even survive.
Each year, some 11,000 Americans sustain spinal cord injury, most often in traffic accidents. Costs of the condition approach $10 billion per year.
Society for Neuroscience
Stem Cell Current Events and Stem Cell News RSSYamanaka eliminates viral vector in stem cell reprogramming
Shinya Yamanaka MD, PhD, of Kyoto University and the Gladstone Institute of Cardiovascular Disease (GICD) has taken another step forward in improving the possibilities for the practical application of induced pluripotent stem (iPS) cell technology.
A link between mitochondria and tumor formation in stem cells
Researchers report on a previously unknown relationship between stem cell potency and the metabolic rate of their mitochondria -a cell's energy makers. Stem cells with more active mitochondria also have a greater capacity to differentiate and are more likely to form tumors.
Landmark study unlocks stem cell, DNA secrets to speed therapies
In a groundbreaking study led by an eminent molecular biologist at Florida State University, researchers have discovered that as embryonic stem cells turn into different cell types, there are dramatic corresponding changes to the order in which DNA is replicated and reorganized.
Mayo researchers explore issues related to multiple myeloma treatment
Multiple myeloma (MM) is a cancer of plasma cells that affects approximately 3 in 100,000 people each year. Although there is no cure for this disease, researchers have developed treatments that help relieve pain, control complications, and slow the progress of MM in many patients.
Emerging model organisms featured in CSH Protocols
Biological research has long relied on a small number of model organisms, species chosen because they are amenable to laboratory research and suitable for the study of a range of biological problems.
Reversible 3-D cell culture gel invented
Singapore's Institute of Bioengineering and Nanotechnology (IBN), which celebrates its fifth anniversary this year, has invented a unique user-friendly gel that can liquefy on demand, with the potential to revolutionize three-dimensional (3D) cell culture for medical research.
What to do with leftover embryos in fertility clinics?
The majority of infertility patients are in favor of using left-over embryos for stem cell research and would also support selling left-over embryos to other couples, according to a recent survey.
Pittsburgh researchers identify source of multipotent stem cells with broad regenerative potential
In a promising finding for the field of regenerative medicine, stem cell researchers at Children's Hospital of Pittsburgh of UPMC have identified a source of adult stem cells found on the walls of blood vessels with the unlimited potential to differentiate into human tissues such as bone, cartilage and muscle.
Stem cells may solve mystery of early pregnancy breast cancer protection
The answer to why an early pregnancy seems to protect against breast cancer could rest with a decrease in stem cells found after animals have given birth, said researchers at Baylor College of Medicine in a report that appears in the current issue of the journal Stem Cell.
Scientists identify genes capable of regulating stem cell function
Scientists from The Forsyth Institute, Boston, MA, and the Howard Hughes Medical Institute at the University of Utah School of Medicine have developed a new system in which to study known mammalian adult stem cell disorders.
More Stem Cell Current Events and Stem Cell News Articles
 | Sex, Science, and Stem Cells by Diana DeGette In August 2001, President George W. Bush announced with fanfare that federal funds would be made available to scientists conducting research on human embryonic stem cell lines—with restrictions. Reading his words, not his lips, was Congresswoman Diana DeGette of Colorado’s First Congressional District, and what she read was this: a ban. “As a practical matter,” scientists could no longer... |
 | The Human Embryonic Stem Cell Debate: Science, Ethics, and Public Policy (Basic Bioethics) CHOICE Outstanding Academic Book for 2002 Human embryonic stem cells can divide indefinitely and have the potential to develop into many types of tissue. Research on these cells is essential to one of the most intriguing medical frontiers, regenerative medicine. It also raises a host of difficult ethical issues and has sparked great public interest and controversy. This book offers a... |
 | Stem Cell Now by Christopher Thomas Scott The essential account of the most important scientific advance—and most volatile ethical debate—of our time While many believe stem cell research holds the key to curing a wide range of ailments, others see this research as opening a Pandora’s box that will devalue human life. In Stem Cell Now, Christopher Scott—executive director of Stanford University’s Stem Cells and Society... |
 | The Stem Cell Controversy: Debating the Issues (Contemporary Issue Series) Stem cell research is headline news. Researchers are eager to move forward, state governments and private foundations are rushing to support it, and the sick and afflicted are desperate for its benefits. Yet powerful forces in our society—led by President George W. Bush—find it morally troubling and they are doing all in their powers to restrict its development beyond a very limited scale. ... |
 | Essentials of Stem Cell Biology by Robert Lanza, E. Donnall Thomas, James Thomson, Roger Pedersen, John Gearhart, Brigid Hogan, Douglas Melton, Michael West This abridged version of the bestselling reference Handbook of Stem Cells, Two-Volume Set attempts to incorporate all the essential subject matter of the original two-volume edition in a single volume. The material has been reworked in an accessible format suitable for students and general readers interested in following the latest advances in stem cells, including full color presentation... |
 | Basic Questions on Genetics, Stem Cell Research and Cloning: Are These Technologies Okay to Use? (Biobasics Series) (BioBasics Series) by Linda K. Bevington, Ray G. Bohlin, Gary P. Stewart, John F. Kilner Cutting-edge medical ethics issues are addressed by nationally recognized experts. The BioBasics Series confronts the maze of challenging questions with biblical responses and uncompromising respect for all human... |
 | The Stem Cell Divide: The Facts, the Fiction, and the Fear Driving the Greatest Scientific, Political, and Religious Debate of Our Time by Michael Bellomo There has been much recent debate about the merits, dangers, and nature of stem cell research. Some see in it the answer to every debilitating disease known to man, while others see it as a step away from human cloning. While the battle has raged, research is moving ahead, and California has already passed a measure that will give $3 billion in support to stem cell research. But as politics,... |
 | Fundamentals of the Stem Cell Debate: The Scientific, Religious, Ethical, and Political Issues Few recent advances in science have generated as much excitement and controversy as human embryonic stem cells. The potential of these cells to replace diseased or damaged cells in virtually every tissue of the body heralds the advent of an extraordinary new field of medicine. Controversy arises, however, because current techniques required to harvest stem cells involve the destruction of the... |
 | Encyclopedia of Stem Cell Research What is a stem cell? We have a basic working definition, but the way we observe a stem cell function in a dish may not represent how it functions in a living organism. Only this is clear: Stem cells are the engine room of multicelluar organisms-both plants and animals. However, controversies, breakthroughs, and frustration continue to swirl in eternal storms through this rapidly moving area of... |
 | Stem Cell Century: Law and Policy for a Breakthrough Technology by Russell Korobkin The explosion of interest in stem cell research raises a raft of controversial policy questions. When should human embryos be used to create stem cells? Should cloning be outlawed? Should egg and tissue donors be paid? Should we allow scientists to patent stem cells? Is the government entitled to a portion of the revenue from stem cell technology created with public funds? How should the... |
| © 2008 BrightSurf.com |